REG - CVS Group plc - SAYE Option Scheme & PDMR Dealing

CVSAnnouncement

28/11/2025 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251128:nRSb5121Ja&default-theme=true

RNS Number : 5121J  CVS Group plc  28 November 2025

 

 

 

 

28 November 2025

CVS Group plc

("CVS" or the "Company")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2025/2026 Save
As You Earn share scheme (the "SAYE Scheme"), which is open to all
employees of the Group, the Executive Directors named below have elected to
participate in the SAYE Scheme and have been granted SAYE Scheme options
as follows:

 

Richard Fairman
              507 SAYE scheme options

Robin Alfonso
                538 SAYE scheme options

Paul Higgs
                    538 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's
ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price
of  1,136 pence per share, representing a 10% discount to
the average closing middle market price for the three dealing days prior
to 1 November 2025, being the invitation date.

 

In response to accepted invitations, a total of  370,637 SAYE Scheme options
over Ordinary Shares were granted on 26 November 2025, equating to 0.52% of
the current issued ordinary share capital.  Subject to the rules of the SAYE
Scheme, these options will be capable of exercise from the maturity date on 1
January 2029.

 

The notification below, made in accordance with the requirements of UK MAR,
provides further detail.

 

Contacts:

CVS Group plc
 
                                      via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)
                                             +44 (0)20
7418 8900

Christopher Golden / James Steel / Andrew Clark

 

  Berenberg (Joint Broker)
 
                     +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

 

Camarco (Financial PR)
 
                       cvsg@camarco.co.uk
(mailto:cvsg@camarco.co.uk)

Ginny
Pulbrook                                                                                                                                 +44
(0)7961 315 138

Letaba Rimell

Tilly Butcher

 

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities /
     person closely associated
 a)  Name                                                         Richard Fairman
 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                  Volume(s)
                                                                  Exercise price of 1,136p  507

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      26 November 2025
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

26 November 2025

f)

Place of the transaction

Off market

 

 1   Details of the person discharging managerial responsibilities /
     person closely associated
 a)  Name                                                         Robin Alfonso
 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                  Volume(s)
                                                                  Exercise price of 1,136p  538

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      26 November 2025
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

26 November 2025

f)

Place of the transaction

Off market

 

 

 1   Details of the person discharging managerial responsibilities /
     person closely associated
 a)  Name                                                         Paul Higgs
 2   Reason for the notification
 a)  Position/status                                              Chief Veterinary Officer & Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                  Volume(s)
                                                                  Exercise price of 1,136p

                                                                               538

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      26 November 2025
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

26 November 2025

f)

Place of the transaction

Off market

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFZMZMVRZGKZM



            Copyright 2019 Regulatory News Service, all rights reserved